The genus Acanthostrongylophora is famous for producing a wide array of manzamine alkaloids as natural hydrochloride salts. An examination of A. ingens has now yielded two tertiary bases, (+)-8-hydroxymanzamine A (1) and (+)-manzamine A (2), by chromatography over alumina using CHCl 3 -MeOH-NH 3 ·H 2 O as solvent. In addition, (+)-8-hydroxymanzamine A hydrochloride (3) and (+)-manzamine A hydrochloride (4) were isolated under the same conditions from the same source by silica gel chromatography. The structures of 1-4 were determined from 1D-and 2D-NMR spectra and by circular dichroism experiments, and the spectral features of the bases 1 and 2 were found to be different from those of the salts 3 and 4. Compounds 3 and 4 were deprotonated by both Al 2 O 3 and strong base to afford 1 and 2, which were converted again to their respective salts 3 and 4. Both the compounds 1 and 3 showed equally potent in vitro antimalarial activity against chloroquinesensitive (D6) and -resistant (W2) strains of P. falciparum (IC 50 = 19.5 and 22.0 ng/mL vs. 27.0 and 36.5 ng/mL, respectively), while 2 was >3-fold less potent than 4 (IC 50 = 20.8 and 25.8 ng/mL vs. 6.1 and 7.3 ng/mL, respectively). Compounds 1, 3 and 4 showed good antimicrobial activities against methicillin-resistant Staphylococcus aureus and Mycobacterium intracellulare and antileishmanial activity against Leishmania donovani promastigotes. In contrast, manzamine A base (2) showed relatively weaker antimicrobial, antileishmanial and cytotoxic activities [towards cancer (HepG 2 : Human hepatocellular carcinoma or hepatoma), and non-cancer cells (VERO: Monkey kidney fibroblast; LLC-PK 11 : Pig kidney epithelial)], compared with salt 4.
alkaloids, (+)-8-hydroxymanzamine A (1) and (+)-manzamine A (2) as free bases (Figure 1 ), using alumina chromatography. In addition, (+)-8-hydroxymanzamine A-HCl (3) and (+)-manzamine A-HCl (4) were also isolated from the same source by silica gel chromatography. Salts 3 and 4 were deprotonated by neutral alumina (Al 2 O 3 ) or strong base (NaOH or Et 3 N) to afford 1 and 2, which were converted again to their respective salts 3 and 4, using HCl/Et 2 O (Figure 2 ). In this paper we report the isolation, spectral features with circular dichroism spectral data, and preparation of 1 and 2 and their salts 3 and 4, as well as their antimalarial, antileishmanial antimicrobial and cytotoxic activities.
The bioassay-guided fractionation of crude acetone extract of A. ingens resulted in the localization of bioactivities in the CH 2 Cl 2 soluble fraction. Centrifugal preparative TLC of the CH 2 Cl 2 fraction, using a silica gel disc and eluting with CH 2 Cl 2 -MeOH-NH 3 ·H 2 O, yielded two fractions (A and B), containing crude alkaloids with R f values of 0.5 and 0.63 (Si gel/ CH 2 Cl 2 -MeOH-NH 3 ·H 2 O; 9:1:0.5), respectively. Subsequent purification of fraction A and B, separately, by CPTLC using alumina discs and CH 2 Cl 2 -MeOH-NH 3 ·H 2 O (9:1:0.5) as solvent, yielded compounds 1 and 2, respectively. On the other hand, fractions A and B were also purified separately over silica gel discs, using the same solvent composition, affording compounds 3 and 4, respectively. Compounds 3 and 4 were identified as (+)-8-hydroxymanzamine A-HCl [7] and (+)manzamine A-HCl [8] , respectively, by comparison of their physical and spectral data with those reported previously. In addition, the identity of 3 was confirmed by direct comparison with an authentic sample of (+)-8-hydroxymanzamine A-HCl, kindly provided by Dr Mark T. Hamann, Department of Pharmacognosy, University of Mississippi. The stereochemistry of 3 and 4 was analyzed using 2D NMR 1 H-1 H NOESY experiments, which were consistent with the stereochemical assignments as 12S, 24R, 25R, 26R and 34R, as established by X-Ray crystallography of 4 [8] .
Compounds 1 and 2 were isolated as amorphous solids and analyzed by positive ion ESIHRMS for C 36 [9] , and the 1 H and 13 C NMR spectroscopic data, together with the 2D NMR, including NOESY correlations, of 1 and 2 are in complete agreement with those reported for both bases.
The N 27 -H deprotonation (base formation) should influence only close environments because nitrogen loses positive charge but keeps its pyramidal sp 3 configuration, i.e. no stereochemical changes are anticipated. However, the strong deshieldings of H-24 of 1 and 2 (δ 3.18, m; δ 3.10, brs), compared with 3 and 4 (δ 2.56, m; δ H-14 2.63, bs), and shielding of H-8 of 2 (7.50, s), compared with 4 (δ H-8 7.80), in the 1 H NMR spectrum has not been addressed by Zhang et al. [9] . This can be explained by the presence of contact ion pairs in the solution of 3 or 4 and, thus, the close spatial proximity of the chloride counter ion (Cl -) (observed by 3D-molecular modeling) has an impact on the adjacent H-24 and H-8 protons. This observation was substantiated by two deshielded chelated protons at δ ~11.9 and ~10.8 (both sharp s), assigned to N 9 -H and N 27 -H, respectively, (i.e., the latter by COSY correlation with H-26) for the salts 3 and 4. In contrast, such chelated protons were absent for 1 and 2, and only N 9 -H proton was observed in the regions of δ 8.9 -9.1. The molecular modeling of 4 showed close spatial relationships between C 12 -OH and N 27 -H (2.12 Å), but the distance between C 12 -OH and N 9 -H (2.84 Å) appears to be large for the formation of an H-bond between them. Therefore, the chelation involves the chloride counter ion (Cl -), which serves as a bridge between N 9 -H and N 27 -H protons, and C 12 -OH proton (i.e., the distance between N 9 -H and Clis 2.20 Å, N 27 -H and Cl -2.01 Å and OH and Cl -2.06 Å, as measured based on X-ray data [8] ). These H-bonds make the salts 3/ 4 quite rigid with restrained rotation of the β-carboline moiety. The molecular modeling of 4 further showed the close spatial proximity of H-24 to both N 9 -H and N 27 -H and consequently to the Clion, which causes deshielding of H-24 for both the salts, and shielding of H-8 for 4. In the cases of bases (1/ 2), the absence of the Clion diminishes such influences on H-24 and H-8 protons.
The optical rotation values of 1 and 2 ([α] D +72, c 0.325 and [α] D +38, c 0.1), taken in CHCl 3 , were found to be approximately 20-25% lower as compared with 3 and 4 ([α] D +89.6, c 0.23, Lit. [7] [α] D +118.5; and [α] D +58.4, c 0.25, Lit. [8] [α] D +50, respectively). The availability of manzamines 1-4 offered the opportunity to assess the potential of circular dichroism for defining the absolute stereochemistry, which has not been reported previously ( Figure 3 ). The CD spectra of 8hydroxymanzamine A-HCl (3) and manzamine A-HCl (4) with their 24R, 26R, 34R absolute configurations [8] displayed a high amplitude positive Cotton effect and low amplitude negative Cotton effect in the 277-279 nm and 365-375 nm regions, respectively. The negative Cotton effect (365-375 nm) is explicable to the C-24(R) chiral center due to n → π* transition. In contrast, compounds 1 and 2 displayed high-and low amplitude positive Cotton effects in the 277-278 and 340-360 nm regions, respectively, of their CD spectra. However, 2 showed two sharp low amplitude positive peaks at 242 and 256 nm, together with the low amplitude negative peak at 369 nm; the latter peak was absent in 1. Conspicuously, both the bases 1 and 2 showed an inverse Cotton effect in the 340-360 nm regions, compared with salts 3 and 4. Such differences in the CD spectra for the salts 3 or 4 and the bases 1 or 2 raise a question since no stereochemical changes are anticipated. However, as mentioned earlier (vide infra), the salts 3 / 4 have rigid cage-like structures set up by H-bonding of N 9 -H and N 27 -H and likely C 12 -OH by the chloride counter ion (Cl -). This restricts free rotation of the β-carboline moiety, responsible for n → π* transition,-and, thus, interrupts the conjugation with the C 10 -C 11 double bond adjacent to the C-24 stereocenter. These influences are absent in the bases 1 and 2, which results in a change in Cotton effects as compared with those of salts 3 and 4.
To date, all the manzamine alkaloids have been isolated as natural hydrochloride salts, except for the two recently reported bases 1 and 2 [9] , using various isolation methodologies [4,5a] . Interestingly, the formation of manzamine free bases by alumina chromatography was largely ignored or escaped close attention. Therefore, for the convenience of future isolation and chromatographic separation, the identities of bases 1 and 2, and salts 3 and 4 were established by preparing them using different adsorbents, solvents and bases, as depicted in Figure  2 . Thus, 3 and 4 (each 5-10 mg) were separately treated with neutral Al 2 prepared from 3 and 4 by the treatment of methanolic NaOH, suggesting they are tertiary bases. The reaction was reversed by treating with HCl/Et 2 O to afford the corresponding hydrochloride salts 3 and 4.
8-Hydroxymanzamine
A tertiary base (1) and its salt 3 showed equally potent in vitro antimalarial activity against chloroquine-sensitive (D6) and -resistant (W2) strains of P. falciparum (IC 50 19.5 and 22.0 ng/mL vs. 27.0 and 36.5 ng/mL, respectively), while 2 was >3-fold less potent than 4 (IC 50 20.8 and 25.8 ng/mL vs. 6.1 and 7.3 ng/mL, respectively) ( Table 1) . On the other hand, 4 was 2-fold more toxic than 2 against kidney fibroblast (VERO) cells (IC 50 430 vs. 975 ng/mL), but its selectivity index for antimalarial activity was higher than 2 (70 vs. 47 for D6 strain and 59 vs. 38 for W2) ( Table 1 ). In addition, compound 2 showed much weaker in vitro antimicrobial activity against Cryptococcus neoformans, methicillinresistant S. aureus and M. intracellularae (IC 50 = 7.25, 1.80, 0.36 μg/mL) compared with 4 (IC 50 = 1.04, 0.19, 0.12 μg/mL) ( Table 2 ). It also showed weaker activity when tested in 5% serum against these organisms (IC 50 = 6.61, 1.15, 1.64 μg/mL). On the other hand, 1 and 3 showed more potent antimycobacterial activity than the drug control ciprofloxacin with IC 50 s of 0.13 and 0.22 vs. 0.48 μg/mL, respectively, against M. intracellulare. As well, all compounds were inactive against the This appears to be the first report of the isolation of manzamine bases 1 and 2, and corresponding salts 3 and 4, from the same natural source. The preparation of bases 1 and 2 from salts 3 and 4 using either alumina or NaOH, and reverse conversion (3/ 4 from 1/ 2) by HCl/Et 2 O, can generally be applied to other known manzamine analogs of 3 and 4. However, formation of artifacts by chromatographic separation over alumina is not uncommon for alkaloids. It is known that Al 2 O 3 has a weak basic nature that is not sufficient for deprotonating compounds 3 and 4. However, interaction on the phase partition could make deprotonation thermodynamically favorable and thus successfully produce bases 1 and 2. The important role of the phase partition is supported by the inability of the weak base NH 3 ·H 2 O to form the desired products. Interestingly, a clear difference in in vitro antimalarial, antileishmanial and antimicrobial activities of 2 was noted due to base formation, as compared with its hydrochloride salt 4.
The lower cytotoxicity of manzamine A free base (2) in comparison with salt (4) against mammalian cells could prove to be beneficial and further investigation is warranted.
Experimental
General: Optical rotations were measured in CHCl 3 using an AUTOPOL IV ® instrument at ambient temperature; IR spectra were obtained using a Bruker Tensor 27 FTIR instrument; circular dichroism (CD) spectra were recorded on a JASCO J-715 polarimeter. The NMR spectra were acquired on a Bruker Avance DRX-500 instrument at 500 MHz ( 1 H), 125 ( 13 C) in CDCl 3 or CD 3 OD, using the residual solvent as int. standard; multiplicity determinations (DEPT) and 2D NMR spectra (COSY, HMQC, HMBC and NOESY) were obtained using standard Bruker pulse programs; HRMS were obtained by direct injection using a Bruker Bioapex-FTMS with electro-spray ionization (ESI 
Isolation of alkaloids:
The crude extract (1.5 g) was extracted with CH 2 Cl 2 (each 50 mL x 3) and the combined extract was filtered and dried (1.1 g). This alkaloid enriched CH 2 Cl 2 fraction demonstrated antimalarial, antileishmanial, antimicrobial and cytotoxic activities. The CH 2 Cl 2 fraction (1 g) was subjected to centrifugal preparative TLC (Chromatotron ® ), using a 4 mm silica gel disc (Analtech), and eluted with CH 2 Cl 2 -MeOH-NH 3 ·H 2 O (99:1:0.1 →95:5:0.1), which afforded 60 fractions (each 20 mL, collected by a fraction collector). Three major alkaloid fractions were pooled by TLC as fractions A (Rf 0.5, 150 mg), B (Rf 0.63, 200 mg) and C (Rf 0.30, 25 mg), with some minor nonalkaloidal impurities. A portion of fractions A and B were purified separately by CPTLC, using 1 mm alumina discs (Analtech) and CH 2 Cl 2 -MeOH-NH 3 ·H 2 O (99:1:0.1) as solvent, and afforded 1 (80 mg) and 2 (120 mg), respectively, as colorless amorphous solids. The remaining portion of fractions A and B, subjected to CPTLC, using 1 mm silica gel discs with CH 2 Cl 2 -MeOH-NH 3 ·H 2 O (99:1:0.1 -97:3:0.1) as solvent yielded 2 (40 mg) and 4 (55 mg), respectively. Unfortunately, compound 1 and 2 failed to generate good crystals in different solvent compositions for X-ray crystallography. (2) (1) by NaOH/MeOH: Compound 3 (5 mg) was dissolved in CH 2 Cl 2 (5 mL), treated with 0.5 mL of methanolic solution of NaOH (0.1 g of NaOH in 20 mL of MeOH) and immediately the reaction mixture was dried using a rotary evaporator. The resulting solid mass was dissolved in 5 mL CH 2 Cl 2 , filtered, and dried to give 1 (4 mg). (4): Compounds 1 and 2 (each 5 mg each) were dissolved in 5 mL CH 2 Cl 2 and treated drop-wise with 0.5 mL HCl/ Et 2 O (2.0 M HCl, Aldrich) and stirred at room temperature under N 2 for 5 min. The reaction mixture was dried in a Speed Vacuum, then re-dissolved in CH 2 Cl 2 and purified by passage through a short silica gel column using CH 2 Cl 2 -MeOH (1:1) as eluant, which yielded products 1 and 2, respectively (each 4 mg). The spectral data (OR, 1 H and 13 C NMR, NOESY) of the products were identical to those observed for (+)-8hydroxymanzamine A and (+)-manzamine A salts.
Preparation of (+)-8-hydroxymanzamine A (1) and (+)-manzamine A

Preparation of (+)-8-hydroxymanzamine A
Preparation of (+)-8-hydroxymanzamine A-HCl (3) and (+)-manzamine A-HCl
Preparation of (+)-manzamine A (2) by alumina column chromatography:
Compound 4 (25 mg) was subjected to column chromatography using neutral alumina mesh # 50-200 (EM Science, 200 mg) and eluted with acetone-n-hexane (1:1) mixture. Compound 2 (23 mg) was eluted in 10 mins, as monitored by TLC and confirmed by NMR spectroscopy.
Antimicrobial assay: All organisms were obtained from the American Type Culture Collection (Manassas, VA) and included the fungi C. albicans ATCC 90028, Cryptococcus neoformans ATCC 90113, and Aspergillus fumigatus ATCC 90906, and the bacteria, methicillin-resistant S. aureus (MRS) ATCC 43300, E. coli ATCC 35218, Pseudomonas aeruginosa ATCC 27853 and Mycobacterium intracellulare ATCC 23068. Susceptibility testing was performed using a modified version of the NCCLS methods [10] [11] [12] . Susceptibility testing of M. intracellulare was achieved using the modified Alamar Blue procedure of Franzblau et al. [13] . Samples were serially-diluted using 0.9% saline and transferred in duplicate to 96 well microplates. Microbial inocula were prepared in assay medium to afford target CFU/mL after addition to the samples. Growth, solvent and media controls were included on each test plate. Assay plates were read at either 630 nm or 544ex/590em (A. fumigatus and M. intracellulare) before and after incubation using either the Biotek Powerwave XS plate reader (Bio-Tek Instruments, Vermont) or the Polarstar Galaxy Plate Reader (BMG Lab Technologies), respectively. Percent growth was plotted vs. test concentration to afford the IC 50 value, or concentration that affords 50% growth relative to controls. The minimum inhibitory concentration (MIC) is defined as the lowest test concentration that allows no detectable growth. The minimum fungicidal or bactericidal concentrations (MFC/MBCs) were determined by removing 5 μL from each clear well, transferring to agar and incubating until growth was seen. The MFC/MBC is defined as the lowest test concentration that allows no growth on agar. The antimicrobial activity in serum was conducted using the standard assay procedures discussed above. Microbial inocula were prepared by correcting the OD 630 of cell/spore suspensions in incubation broth supplemented with 5% bovine calf serum (Hyclone, Logan, UT) to afford final target inocula. Drug controls [Ciprofloxacin (ICN Biomedicals, Ohio) for bacteria and Amphotericin B (ICN Biomedicals, Ohio) for fungi] were included in each assay.
